$GOOGL

Alphabet price target raised to $450 from $420 at Evercore ISI

Evercore ISI raised Alphabet's (GOOGL) price target to $450 from $420, citing a proprietary survey. The survey shows Google's search engine market share at 78%, up from a low of 70% in 2024-2025. Gemini's share also increased, narrowing the gap with ChatGPT to 3 points.

Original reporting
Published Sep 16, 2026, 11:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 7:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alphabet price target raised to $450 from $420 at Evercore ISI — source image
Decision brief

The 30-second read

$GOOGLBullishMed
01

Why it matters

The price‑target increase reflects confidence in Alphabet's core search moat and AI progress, likely supporting short‑term bullish sentiment.

02

Market read

Analyst target raise adds a positive catalyst for Alphabet and may influence tech sector sentiment.

03

What to watch

Potential regulatory scrutiny of AI data practices could temper upside.

Relevance 7/10Novelty 6/10Timing: today

Background

Alphabet dominates US search with 78% primary engine selection; its AI offering Gemini is gaining market share against competitors.

Company-level read

Ticker impact

$GOOGLBullishMedium confidence
Context

Evercore ISI raised Alphabet's price target to $450 from $420, citing strong search market share and AI service gains.

Expected impact

Potential modest upside of 2‑4% over the next week.

Evidence & confidence

Target raise reflects improved competitive positioning; however, broader market factors dominate price moves.

Market effects

Reinforces bullish outlook for the online search and digital advertising sector.

May lift US large‑cap tech indices modestly.

Signals continued strength of AI‑driven search services worldwide.

Counterpoint

Target raise may already be priced in; risk of overvaluation if AI competition intensifies.

Key entities

  • Alphabet Inc.

    Parent of Google, listed on NASDAQ under GOOGL.

  • Evercore ISI

    Equity research analyst firm that issued the target raise.

Related articles

$NVDALow

Tokenized Stocks 2026: How 63 U.S. Shares Will Trade 24/7

OKXICE, a joint venture between OKX and Intercontinental Exchange (ICE), plans to list tokenized versions of 63 U.S. stocks, including Nvidia, Tesla, and Apple, on a blockchain platform. The SEC's new 'innovation exemption' allows this trading, with a 0.25% daily volume cap per stock. Trading may begin as early as November, pending no objections from listed companies. Tokenized stocks will trade 24/7, but liquidity and price accuracy may vary, especially during weekends.

$GOOGLMed

Google Unveils 'Playground,' Brings AI Gaming To 'Tens Of Millions' Creators

Google and Unity Software partnered to launch an AI-powered gaming platform, Playground, which allows users to create games without coding. Unity CEO Mathew Bromberg said the goal is to simplify game creation for millions. The platform will integrate with Unity's software later this year, starting with mobile gaming. Google DeepMind's expertise in AI and gaming is expected to drive the initiative.

$CEGMed

Constellation, Vistra uprate deals signal fastest path to new nuclear megawatts

Constellation Energy, Google, and the U.S. DOE announced a 20-year power purchase agreement for 890 MW of nuclear uprates at 11 reactors, with Constellation investing $4.3B. The DOE also committed up to $4.2B for Vistra's nuclear upgrades, adding 433 MW of capacity. Both deals aim to boost existing nuclear capacity to meet rising electricity demand, particularly in the PJM Interconnection.

$METAHighAI 8/10

Meta, Google Put $300M Into Zuckerberg-Backed $1.8B AI Biology Bet

Meta (META) and Alphabet (GOOGL) units are investing $300M in Biohub's $1.8B Virtual Biology Initiative, aiming to create AI models that predict cell behavior. The project, backed by Mark Zuckerberg, seeks to generate large datasets for biological research, with commercial partners gaining early access. Biohub expects its first dataset within a year and predictive models within five years, though the effectiveness of data scaling in biology remains uncertain.